Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination

  • Z. Farfel
  • , S. Konen
  • , E. Wiertz
  • , R. Klapmuts
  • , P. A.K. Addy
  • , E. Hanski*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Bordetella pertussis produces several potential virulence factors. One of these is an adenylate cyclase which penetrates eukaryotic cells, is activated by calmodulin and generates high levels of intracellular cAMP. We have found that pertussis infection in man leads to production of high titres (2000-8000) of anti-B. pertussis adenylate cyclase antibodies. Such antibodies also are produced after pertussis vaccination. They persist into adulthood, cross the placenta and disappear a few months after birth. The anti-adenylate cyclase antibodies found in human serum during pertussis infection do not neutralise the catalytic and penetrative activities of the enzyme.

Original languageEnglish
Pages (from-to)173-177
Number of pages5
JournalJournal of Medical Microbiology
Volume32
Issue number3
DOIs
StatePublished - 1990
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Antibodies to Bordetella pertussis adenylate cyclase are produced in man during pertussis infection and after vaccination'. Together they form a unique fingerprint.

Cite this